Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Survival benefit associated with human anti-mouse antibody (HAMA) in patients with B-cell malignancies.

Azinovic I, DeNardo GL, Lamborn KR, Mirick G, Goldstein D, Bradt BM, DeNardo SJ.

Cancer Immunol Immunother. 2006 Dec;55(12):1451-8. Epub 2006 Feb 22.

PMID:
16496145
2.
3.

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.

Mirick GR, Bradt BM, Denardo SJ, Denardo GL.

Q J Nucl Med Mol Imaging. 2004 Dec;48(4):251-7. Review.

4.

Characterization of human IgG antimouse antibody in patients with B-cell malignancies.

DeNardo GL, Mirick GR, Kroger LA, Bradt BM, Lamborn KR, DeNardo SJ.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):4013S-21S.

5.
6.

Human antiglobulin response to foreign antibodies: therapeutic benefit?

DeNardo GL, Bradt BM, Mirick GR, DeNardo S.

Cancer Immunol Immunother. 2003 May;52(5):309-16. Epub 2003 Mar 4. Review.

PMID:
12700946
7.
9.

Focal inflammation in the brain: role in Alzheimer's disease.

Cooper NR, Bradt BM, O'Barr S, Yu JX.

Immunol Res. 2000;21(2-3):159-65. Review.

PMID:
10852113
10.
11.

Substrate specificities of murine C1s.

Ogata RT, Low PJ, Bradt BM, Cooper NR.

J Immunol. 1994 Jun 15;152(12):5890-5.

PMID:
8207214
12.

Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein.

Ogata RT, Mathias P, Bradt BM, Cooper NR.

J Immunol. 1993 Mar 15;150(6):2273-80.

PMID:
8450212
13.

CR2 complement receptor.

Cooper NR, Bradt BM, Rhim JS, Nemerow GR.

J Invest Dermatol. 1990 Jun;94(6 Suppl):112S-117S. Review.

PMID:
2161885
14.

Murine complement component C4 and sex-limited protein: identification of amino acid residues essential for C4 function.

Ogata RT, Cooper NR, Bradt BM, Mathias P, Picchi MA.

Proc Natl Acad Sci U S A. 1989 Jul;86(14):5575-9.

15.

Transfected cDNA directs expression of hemolytically active murine C4 in cultured mouse and monkey cells.

Picchi MA, Bradt BM, Cooper NR, Ogata RT.

Complement Inflamm. 1989;6(6):442-52.

PMID:
2513164
16.

Epstein-Barr virus regulates activation and processing of the third component of complement.

Mold C, Bradt BM, Nemerow GR, Cooper NR.

J Exp Med. 1988 Sep 1;168(3):949-69.

17.

Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.

Mold C, Bradt BM, Nemerow GR, Cooper NR.

J Immunol. 1988 Jun 1;140(11):3867-74.

PMID:
2836501
18.

CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.

Mold C, Nemerow GR, Bradt BM, Cooper NR.

J Immunol. 1988 Mar 15;140(6):1923-9.

PMID:
2831273

Supplemental Content

Loading ...
Support Center